We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+14.75%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.48B
AUM Growth
+$231M
Cap. Flow
-$87.3M
Cap. Flow %
-2.51%
Top 10 Hldgs %
17.4%
Holding
433
New
64
Increased
81
Reduced
104
Closed
64

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$29M
2
CNC icon
Centene
CNC
+$17.6M
3
KBR icon
KBR
KBR
+$16.5M
4
CDW icon
CDW
CDW
+$16.2M
5
IQV icon
IQVIA
IQV
+$16.1M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$27M
2
PVH icon
PVH
PVH
+$18.7M
3
TPR icon
Tapestry
TPR
+$18.2M
4
IART icon
Integra LifeSciences
IART
+$18.1M
5
MTZ icon
MasTec
MTZ
+$17.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Technology 18%
3 Consumer Discretionary 12.44%
4 Industrials 12.24%
5 Energy 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATVI
26
DELISTED
Activision Blizzard
ATVI
$29.7M 0.85%
356,600
+28,703
+9% +$2.18M
MS icon
27
Morgan Stanley
MS
$324B
$28.2M 0.81%
606,598
-144,772
-19% -$7.07M
TIF
28
DELISTED
Tiffany & Co.
TIF
$27.2M 0.78%
211,121
+82,672
+64% +$10.8M
GOOG icon
29
Alphabet (Google) Class C
GOOG
$4.18T
$26.8M 0.77%
448,980
-4,600
-1% -$276K
HD icon
30
Home Depot
HD
$305B
$26.1M 0.75%
126,178
-1,520
-1% -$306K
CDW icon
31
CDW
CDW
$19.2B
$25.3M 0.73%
284,669
+186,964
+191% +$16.2M
SCHW
32
Charles Schwab
SCHW
$186B
$24.5M 0.7%
497,482
-529,461
-52% -$27M
CZR icon
33
Caesars Entertainment
CZR
$6.04B
$23.2M 0.67%
477,885
-20,095
-4% -$912K
LGND icon
34
Ligand Pharmaceuticals
LGND
$5.52B
$22.5M 0.65%
131,125
-16,696
-11% -$2.52M
GDOT icon
35
Green Dot
GDOT
$752M
$21.5M 0.62%
241,704
-9,385
-4% -$780K
BURL icon
36
Burlington
BURL
$14.3B
$20.6M 0.59%
126,350
+72,730
+136% +$11.6M
MOH icon
37
Molina Healthcare
MOH
$10.8B
$20.4M 0.59%
136,980
-4,440
-3% -$567K
META icon
38
Meta Platforms (Facebook)
META
$1.71T
$20.3M 0.58%
123,278
-95,866
-44% -$17.4M
INXN
39
DELISTED
Interxion Holding N.V.
INXN
$20M 0.57%
296,591
+5,675
+2% +$368K
FIVE icon
40
Five Below
FIVE
$13B
$19.8M 0.57%
152,130
+21,875
+17% +$2.43M
BEAT
41
DELISTED
BioTelemetry, Inc.
BEAT
$19.7M 0.57%
305,306
+585
+0.2% +$32.6K
STRA icon
42
Strategic Education
STRA
$1.85B
$19.5M 0.56%
142,394
+49,249
+53% +$6.32M
GTLS
43
DELISTED
Chart Industries
GTLS
$19.4M 0.56%
247,730
-23,465
-9% -$1.74M
HAE icon
44
Haemonetics
HAE
$4.83B
$18.6M 0.53%
162,222
-64,380
-28% -$6.66M
NVCR icon
45
NovoCure
NVCR
$1.88B
$18.6M 0.53%
354,428
-10,525
-3% -$419K
AMAT icon
46
Applied Materials
AMAT
$334B
$18.5M 0.53%
478,938
-5,950
-1% -$263K
MCHP icon
47
Microchip Technology
MCHP
$38.8B
$18.5M 0.53%
469,058
-314,776
-40% -$13.9M
VG
48
DELISTED
Vonage Holdings Corporation
VG
$18.5M 0.53%
1,304,537
-87,560
-6% -$1.2M
CNC icon
49
Centene
CNC
$33.4B
$18.3M 0.53%
+253,440
New +$17.6M
NGVT icon
50
Ingevity
NGVT
$2.33B
$18.2M 0.52%
178,624
+4,795
+3% +$463K
1
2
3 4 5

Similar funds

MSC
MUFG Securities (Canada) New York $3.71B AUM 38.19% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.7B AUM 39.18% 1-Year Est. Return
OH
Osiris Holdings Monaco $3.72B AUM
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.7B AUM 32.64% 1-Year Est. Return
MCM
MKP Capital Management New York $3.7B AUM 23.18% 1-Year Est. Return

Castleark Management's Q3 2018 Portfolio in Review

As of Q3 2018, Castleark Management held 433 positions worth $3.48B, up 7.1% from $3.25B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Castleark Management's Q3 2018 filing shows 64 new, 81 increased, 104 reduced and 64 closed positions. Its largest new stake was Eli Lilly: 289,654 shares worth $31.1M. The largest sale was Charles Schwab, an estimated $27M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Castleark Management's largest Q3 2018 buy was Eli Lilly: 289,654 shares worth $31.1M.
  • Castleark Management added most to CDW in Q3 2018, an estimated $16.2M increase.
  • Castleark Management's biggest Q3 2018 reduction was Charles Schwab, cutting an estimated $27M.
  • Castleark Management fully exited Tapestry in Q3 2018, selling an estimated $18.2M.
  • Castleark Management's ten largest holdings make up 17% of its $3.48B portfolio in Q3 2018.
  • Castleark Management opened 64 new positions and closed 64 in Q3 2018.
  • Castleark Management's portfolio value rose 7.1% quarter-over-quarter to $3.48B.

Based on Castleark Management's 13F filing for Q3 2018, filed 15 Nov 2018.